Prevalence of inherited prothrombotic abnormalities and central venous catheter-related thrombosis in haematopoietic stem cell transplants recipients

Bone Marrow Transplantation

Volumn 36, Issue 10, 2005, Pages 885-889

  Abdelkefi, A ^a   Romdhane, N Ben ^b   Kriaa, A ^b   Chelli, M ^c   Torjman, L ^a   Ladeb, S ^a   Othman, T Ben ^a   Lakhal, A ^a   Guermazi, S ^d   Hassen, A Ben ^a   Ladeb, F ^c   Abdeladhim, A Ben ^a  

^a CENTRE NATIONAL DE GREFFE DE MOELLE OSSEUSE   (Tunisia)

^b LA RABTA HOSPITAL   (Tunisia)

^c Institut National Mohammed Kassab d'Orthopedie   (Tunisia)

^d CHARLES NICOLLE HOSPITAL   (Tunisia)

Author keywords

Central venous catheter; Haematopoietic stem cell transplant; Inherited prothrombotic abnormalities; Thrombosis

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 5 LEIDEN; HEPARIN; POLYURETHAN; PROTEIN C; PROTEIN S; PROTHROMBIN;

ADOLESCENT; ADULT; ANTICOAGULANT THERAPY; ANTITHROMBIN DEFICIENCY; ARTICLE; BLOOD CLOTTING; CENTRAL VENOUS CATHETER; CHEMOPROPHYLAXIS; CHILD; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; GENE MUTATION; GENETIC DISORDER; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INCIDENCE; MALE; MEDICAL DECISION MAKING; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; RECIPIENT; RISK ASSESSMENT; THROMBOSIS;

BLOOD COAGULATION FACTORS; CATHETERIZATION; CATHETERIZATION, CENTRAL VENOUS; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; THROMBOPHILIA; THROMBOSIS;

EID: 27844572535     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705156     Document Type: Article

References (27)

1. Madero L, Ruano D, Villa M et al. Non-tunnelled catheters in children undergoing bone marrow transplantation. Bone Marrow Transplant 1996; 17: 87-89.
2. Kumagai T, Sakamaki H, Tanikawa S et al. Utility and safety of Hickman catheters for venous access after bone marrow transplantation. Intern Med 1998; 37: 286-291.
3. Male C, Chait P, Andrew M et al. Central venous line-related thrombosis in children: Association with central venous line location and insertion technique. Blood 2003; 101: 4273-4278.
4. McGee DC, Gould MK. Preventing complications of central venous catheterization. N Engl J Med 2003; 348: 1123-1133.
5. Monreal M, Raventos A, Lerma R et al. Pulmonary embolism in patients with upper extremity DVT associated to venous central lines - a prospective study. Thromb Haemost 1994; 72: 548-550.
6. Ross AH, Griffith CD, Anderson JR, Grieve DC. Thromboembolic complications with silicone elastomer subclavian catheters. J Parenter Enteral Nutr 1982; 6: 61-63.
7. Bozzetti F, Scarpa D, Terno G et al. Subclavian venous thrombosis due to indwelling catheters: A prospective study on 52 patients. J Parenter Enteral Nutr 1983; 7: 560-562.
8. Haire WD, Lieberman RP, Edney J et al. Hickman catheter-induced thoracic vein thrombosis. Frequency and long-term sequelae in patients receiving high-dose chemotherapy and marrow transplantation. Cancer 1990; 66: 900-908.
9. Conlan MG, Haire WD, Lieberman RP et al. Catheter-related thrombosis in patients with refractory lymphoma undergoing autologous stem cell transplantation. Bone Marrow Transplant 1991; 7: 235-240.
10. Boraks P, Scale J, Price J et al. Prevention of central venous catheter-associated thrombosis using minidose warfarin in patients with haematological malignancies. Br J Haematol 1998; 101: 483-486.
11. Emmerich J, Rosendaal FR, Cattaneo M et al. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism- pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Thromb Haemost 2001; 86: 809-816.
12. Fijnheer R, Paijmans B, Verdonck LF et al. Factor V Leiden in central venous catheter-associated thrombosis. Br J Haematol 2002; 118: 267-270.
13. Bertina RM, Koeleman BP, Koster T et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67.
14. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-3703.
15. Martinelli I, Mannucci PM, De Stefano V et al. Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: A study of 150 families. Blood 1998; 92: 2353-2358.
16. Seldinger S. Catheter replacement of the needle in percutaneous arteriography: A new technique. Acta Radiol 1953; 39: 368-376.
17. Koksoy C, Kuzu A, Kutlay J et al. The diagnostic value of colour Doppler ultrasound in central venous catheter related thrombosis. Clin Radiol 1995; 50: 687-689.
18. Prandoni P, Polistena P, Bernardi E et al. Upper-extremity deep vein thrombosis. Risk factors, diagnosis, and complications. Arch Intern Med 1997; 157: 57-62.
19. Patel MC, Berman LH, Moss HA et al. Subclavian and internal jugular veins at Doppler US: Abnormal cardiac pulsatility and respiratory phasicity as a predictor of complete central occlusion. Radiology 1999; 211: 579-583.
20. Ratcliffe M, Broadfoot C, Davidson M et al. Thrombosis, markers of thrombotic risk, indwelling of central venous catheters and antithrombotic prophylaxis using low-dose warfarin in subjects with malignant disease. Clin Lab Haematol 1999; 21: 353-357.
21. Riordan M, Weiden PL. Factor V leiden mutations does not account for central venous catheter-related thrombosis. Am J Hematol 1998; 58: 150-152.
22. van Rooden CJ, Rosendaal FR, Meinders AE et al. The contribution of factor V Leiden and prothrombin G20210A mutation to the risk of central venous catheter-related thrombosis. Haematologica 2004; 89: 201-206.
23. Bern MM, Lokich JJ, Wallach SR et al. Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial. Ann Intern Med 1990; 112: 423-428.
24. Monreal M, Alastrue A, Rull M et al. Upper extremity deep venous thrombosis in cancer patients with venous access devices: Prophylaxis with a low molecular weight heparin (Fragmin). Thromb Haemost 1996; 75: 251-253.
25. Abdelkefi A, Ben Othman T, Kammoun L et al. Prevention of central venous line-related thrombosis by continuous infusion of low-dose unfractionated heparin, in patients with haemato-oncological disease. Throm Haemost 2004; 92: 654-661.
26. van Rooden CJ, Monraats PS, Kettenis I et al. Low physician compliance of prescribing anticoagulant prophylaxis in patients with solid tumor or haematological malignancies and central vein catheters. J Thromb Hemost 2003; 1: 1842-1843.
27. Carr KM, Rabinowitz I. Physician compliance with warfarin prophylaxis for central venous catheters in patients with solid tumors. J Clin Oncol 2000; 18: 3665-3667.